Partner Frank Murray was quoted in a Bloomberg article, “Amazon’s $10 Billion Pentagon Challenge: Proving Trump Meddled,” about Amazon’s uphill battle to overturn a Pentagon decision to award a $10 billion cloud-computing contract to archrival Microsoft.
To help make its case, Murray said, Amazon could examine whether there were any differences between how the companies’ bids were evaluated by lower level technical staff and top Pentagon officials. If top officials overrode the recommendation of their technical staff, that could be a significant piece of evidence for Amazon. “The nuts and bolts of the case are going to be: how were the proposals evaluated? And were they reasonable?” he said.
(Subscription required)
To help make its case, Murray said, Amazon could examine whether there were any differences between how the companies’ bids were evaluated by lower level technical staff and top Pentagon officials. If top officials overrode the recommendation of their technical staff, that could be a significant piece of evidence for Amazon. “The nuts and bolts of the case are going to be: how were the proposals evaluated? And were they reasonable?” he said.
(Subscription required)
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.